妊娠合并母体肥胖的短期新生儿结局
该研究为2008至2011年25家医院随机选取分娩日的队列二次分析,纳入24至42周单胎分娩,按体重指数分组并以1:1匹配正常及超重组,采用改良泊松回归分析。共纳入52162例,复合新生儿病率为4.0%;病态肥胖组风险升高(调整比值比1.33,95%置信区间1.17-1.52),肥胖组与超病态肥胖组无显著关联。
要点
- 病态肥胖(体重指数40.0-49.9)孕妇的新生儿复合病率风险升高,调整比值比1.33(95%置信区间1.17-1.52)。
- 肥胖(体重指数30.0-39.9)与超病态肥胖(体重指数≥50)组复合新生儿病率无显著关联。
- 共52162例纳入分析,复合新生儿病率为4.0%(2103例)。
核心结论
- 与参照组相比,病态肥胖孕妇的新生儿复合病率风险更高;肥胖组和超病态肥胖组未见显著关联。
研究设计与样本
- 研究为2008至2011年在25家医院随机选取分娩日的分娩队列的二次分析,数据由认证摘录员收集。
- 分析纳入24至42周单胎分娩,按孕前最近体重和身高计算体重指数并分为正常及超重组(参照组,18.5-29.9 kg/m2)、肥胖组(30.0-39.9 kg/m2)、病态肥胖组(40.0-49.9 kg/m2)和超病态肥胖组(≥50 kg/m2)。
- 参照组按年龄、种族和民族、既往剖宫产、孕前糖尿病、慢性高血压、产次、吸烟和保险状态与各肥胖组以1:1比例匹配。
- 最终模型纳入37周前早产和子痫前期或子痫。
主要发现
- 倾向评分匹配后共纳入52162例患者及其新生儿,其中肥胖组21704例(41.6%)、病态肥胖组3787例(7.3%)、超病态肥胖组590例(1.1%)。
- 2103例新生儿(4.0%)发生复合结局。
- 病态肥胖组新生儿复合病率风险较参照组升高33%(调整比值比1.33;95%置信区间1.17-1.52)。
- 肥胖组(调整比值比1.05;95%置信区间0.97-1.14)和超病态肥胖组(调整比值比1.18;95%置信区间0.86-1.64)未见显著关联。
关键数值与推荐
- 复合新生儿病率包括胎儿或新生儿死亡、缺氧缺血性脑病、呼吸窘迫综合征、脑室内出血3或4级、坏死性小肠结肠炎、败血症、产伤、惊厥或使用呼吸机。
- 病态肥胖组调整比值比1.33(95%置信区间1.17-1.52)。
- 肥胖组调整比值比1.05(95%置信区间0.97-1.14)。
- 超病态肥胖组调整比值比1.18(95%置信区间0.86-1.64)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maternal obesity complicates a high number of pregnancies. The degree to which neonatal outcomes are adversely affected is unclear. OBJECTIVE: This study aimed to evaluate neonatal outcomes of pregnancies complicated by maternal obesity. STUDY DESIGN: This study was a secondary analysis of a cohort of deliveries occurring on randomly selected days at 25 hospitals from 2008 to 2011. Data were collected by certified abstractors. This analysis included singleton deliveries between 24 and 42 weeks of gestation. Body mass index was calculated on the basis of maternal height and most recent weight before delivery. Normal and overweight (reference group; body mass index, 18.5-29.9 kg/m2), obese (body mass index, 30.0-39.9 kg/m2), morbidly obese (body mass index, 40.0-49.9 kg/m2), and super morbidly obese (body mass index, ≥50 kg/m2) patients were compared. Patients in the reference group were matched in a 1:1 ratio with those in all other groups with obesity using the baseline characteristics of age, race and ethnicity, previous cesarean delivery, preexisting diabetes mellitus, chronic hypertension, parity, cigarette use, and insurance status. The primary outcome was composite neonatal morbidity, including fetal or neonatal death, hypoxic-ischemic encephalopathy, respiratory distress syndrome, intraventricular hemorrhage grade 3 or 4, necrotizing enterocolitis, sepsis, birth injury, seizures, or ventilator use. We used a modified Poisson regression to examine the associations between body mass index and composite neonatal outcome. Preterm delivery at <37 weeks of gestation and the presence of maternal preeclampsia or eclampsia were included in the final model because of their known associations with neonatal outcomes. RESULTS: Overall, 52,162 patients and their neonates were included after propensity score matching. Of these, 21,704 (41.6%) were obese, 3787 (7.3%) were morbidly obese, and 590 (1.1%) were super morbidly obese. A total of 2103 neonates (4.0%) had the composite outcome. Neonates born to pregnant people with morbid obesity had a 33% increased risk of composite neonatal morbidity compared with those in the reference group (adjusted odds ratio, 1.33; 95% confidence interval, 1.17-1.52), but no significant association was observed for persons with obesity (adjusted odds ratio, 1.05; 95% confidence interval, 0.97-1.14) or with super morbid obesity (adjusted odds ratio, 1.18; 95% confidence interval, 0.86-1.64). CONCLUSION: Compared with the reference group, gravidas with morbid obesity were at higher risk of composite neonatal morbidity.
引用
- Dinsmoor MJ, Ugwu LG, Bailit JL, et al. Short-term neonatal outcomes of pregnancies complicated by maternal obesity. Am J Obstet Gynecol MFM. 2023. PMID: 36690180. doi:10.1016/j.ajogmf.2023.100874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。